RecruitingNCT05650905

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

Sponsor

Medical University of Vienna

Enrollment

90 participants

Start Date

Jul 26, 2021

Study Type

OBSERVATIONAL

Conditions

COVID-19 Post-COVID-19 Syndrome

Summary

The Study objective is to measure retinal neurovascular coupling and blood flow parameters in patients previously infected with COVID-19, long COVID-19 and healthy age- and sex- matched control subjects

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Dynamic Vessel Analyzer (DVA), a medical device called Fourier domain optical coherence tomography (FDOCT), and others for people with covid-19 and post-covid-19 syndrome. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDynamic Vessel Analyzer (DVA)

Retinal neurovascular coupling, Retinal vessel diameters and Retinal oxygen saturation will be assessed using the DVA

DEVICEFourier domain optical coherence tomography (FDOCT)

Retinal blood velocities and Retinal blood flow will be assessed using the FDOCT

DEVICEOptical coherence tomography (OCT)

Retinal nerve fiber layer thickness, Central retinal thickness and Retinal vessel density will be assessed using the OCT

DEVICELaser Speckle Flowgraphy (LSFG)

Normalized blur and Relative flow volume will be assessed using the LSFG

DIAGNOSTIC_TESTProteomics and Metabolites in Plasma, tear fluid and finger sweat

Proteomics and Metabolites in Plasma, tear fluid and finger sweat will be assessed using a Blooddraw, filter paper and Schirmer-test

Locations(1)

Medical University of Vienna, Department of Clinical Pharmacology

Vienna, State of Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05650905

Related Trials

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

NCT075363086 locations

Viral Infections in Healthy and Immunocompromised Hosts

NCT013060841 location

Longitudinal Population-based Observational Study of COVID-19 in the UK Population

NCT043305991 location

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

NCT0380892228 locations

Patient-Centered Practical Vaccine Talk For Busy Clinicians

NCT076517611 location